MCL-1 as a tumor microenvironment-linked survival node in cholangiocarcinoma

Area of Science:

• Oncology
• Cancer Biology
• Molecular Therapeutics

Background:

• Cholangiocarcinoma (CCA) is a lethal cancer with poor prognosis.
• Current therapies offer limited long-term benefits due to tumor heterogeneity and desmoplasia.
• Survival mechanisms connecting tumor cells and the microenvironment need further elucidation.

Purpose of the Study:

• To reframe myeloid cell leukemia-1 (MCL-1) as a tumor microenvironment-linked survival node in CCA.
• To explore the role of MCL-1 in mediating resistance to apoptosis and chemotherapy.
• To investigate the association of MCL-1 expression with CCA biology and tumor status.

Main Methods:

• Literature review and perspective synthesis on MCL-1 function in CCA.
• Analysis of experimental data on MCL-1's interaction with apoptosis, IL-6, LIF, PI3K/AKT, and FGFR pathways.
• Examination of MCL-1 expression in a cholangiocarcinoma tissue microarray.

Main Results:

• MCL-1 mediates resistance to TRAIL-induced apoptosis and chemotherapy.
• MCL-1 signaling is reinforced by IL-6 and LIF, impacting tumor cell survival.
• MCL-1 positivity was found in 74.1% of primary CCAs and associated with tumor status (pT).

Conclusions:

• MCL-1 functions as a critical survival node at the interface of desmoplasia, cytokine signaling, and mitochondrial fitness in CCA.
• MCL-1 expression serves as a potential tissue-level indicator of survival-favored CCA biology.
• Targeting MCL-1 may offer a therapeutic strategy by disrupting tumor-promoting microenvironmental circuitry.